Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

被引:4
作者
Yang, Cheng [1 ]
Wu, Yong-Jian [1 ]
Qian, Jie [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
关键词
statins; cardiovascular disease; lipid-lowering; cornerstone; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; LOWERING LDL CHOLESTEROL; RANDOMIZED CONTROLLED-TRIALS; CONSENSUS DECISION PATHWAY; CHRONIC KIDNEY-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; ISCHEMIC-STROKE;
D O I
10.31083/j.rcm2412373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis, the key pathogenesis of cardiovascular disease, is a leading cause of death and disability worldwide. Statins are first-line lipid-lowering drugs, which have been demonstrated to be powerful agents for anti-atherosclerosis. Numerous studies have confirmed the cardiovascular benefits and long-term safety of statins in a wide range of patients. Statins play an indispensable and irreplaceable part in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). In this article, we summarize the evolution of statins and their role in the treatment of cholesterol. The anti-atherosclerotic mechanism of statins, its efficacy, safety and clinical outcomes in secondary and primary prevention of ACSVD in different patient populations, the combination treatment effects, and guideline recommendations are also detailed. This paper highlights the profound significance of statins as the most successful anti-atherogenic drug in the cardiovascular field.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Controlling the thickness of the atherosclerotic plaque by statin medication
    Formanowicz, Dorota
    Krawczyk, Jacek B.
    [J]. PLOS ONE, 2020, 15 (10):
  • [42] Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis
    Alberton, M.
    Wu, P.
    Druyts, E.
    Briel, M.
    Mills, E. J.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (02) : 145 - 157
  • [43] Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors
    Hsu, Chia-Yun
    Chen, Wen-Jone
    Chen, Ho-Ming
    Tsai, Hsin-Yi
    Hsiao, Fei-Yuan
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 415 - 423
  • [44] Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease
    Thanassoulis, George
    Williams, Ken
    Altobelli, Kathleen Kimler
    Pencina, Michael J.
    Cannon, Christopher P.
    Sniderman, Allan D.
    [J]. CIRCULATION, 2016, 133 (16) : 1574 - +
  • [45] Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
    Lee, Myunhee
    Choi, Won Jung
    Lee, Yunhee
    Lee, Kyusup
    Park, Mahn-Won
    Myong, Jun-Pyo
    Kim, Dae-Won
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [46] Atherosclerotic Cardiovascular Disease in a Patient With Metabolic Syndrome
    Zelig, Rena
    Cohen, Marc
    Davidson, Patricia
    Ziegler, Jane
    [J]. TOPICS IN CLINICAL NUTRITION, 2014, 29 (02) : 165 - 186
  • [47] 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease--- Part I
    Chao, Ting-Hsing
    Lin, Tsung-Hsien
    Cheng, Cheng-, I
    Wu, Yen-Wen
    Ueng, Kwo-Chang
    Wu, Yih-Jer
    Lin, Wei-Wen
    Leu, Hsing-Ban
    Cheng, Hao-Min
    Huang, Chin-Chou
    Wu, Chih-Cheng
    Lin, Chao-Feng
    Chang, Wei-Ting
    Pan, Wen-Han
    Chen, Pey-Rong
    Ting, Ke-Hsin
    Su, Chun-Hung
    Chu, Chih-Sheng
    Chien, Kuo-Liong
    Yen, Hsueh-Wei
    Wang, Yu-Chen
    Su, Ta-Chen
    Liu, Pang-Yen
    Chang, Hsien-Yuan
    Chen, Po-Wei
    Jimmy, Jyh-Ming
    Juang, Jyh-Ming Jimmy
    Lu, Ya-Wen
    Lin, Po-Lin
    Wang, Chao-Ping
    Ko, Yu-Shien
    Chiang, Chern-En
    Hou, Charles Jia-Yin
    Wang, Tzung-Dau
    Lin, Yen-Hung
    Huang, Po-Hsun
    Chen, Wen-Jone
    [J]. ACTA CARDIOLOGICA SINICA, 2024, 40 (05) : 479 - 543
  • [48] Oral health and atherosclerotic cardiovascular disease: A review
    Gianos, Eugenia
    Jackson, Elizabeth A.
    Tejpal, Astha
    Aspry, Karen
    O'Keefe, James
    Aggarwal, Monica
    Jain, Ankur
    Itchhaporia, Dipti
    Williams, Kim
    Batts, Travis
    Allen, Kathleen E.
    Yarber, Clark
    Ostfeld, Robert J.
    Miller, Michael
    Reddy, Koushik
    Freeman, Andrew M.
    Fleisher, Kenneth E.
    [J]. AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 7
  • [49] Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease
    Barquera, Simon
    Pedroza-Tobias, Andrea
    Medina, Catalina
    Hernandez-Barrera, Lucia
    Bibbins-Domingo, Kirsten
    Lozano, Rafael
    Moran, Andrew E.
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2015, 46 (05) : 328 - 338
  • [50] Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
    Kerola, Anne Mirjam
    Rollefstad, Silvia
    Semb, Anne Grete
    [J]. EUROPEAN CARDIOLOGY REVIEW, 2021, 16